Biological sex influences the biodistribution and absorbed dose of 131I (iodide) in mice
Abstract Biological sex can influence radiation response, but sex is rarely considered in biodistribution studies of radionuclides. 131 I is used clinically and may be released at nuclear accidents. The aim was to investigate differences in biodistribution and dosimetry of 131 I (iodide) between male and female mice. C57BL/6N mice received 170 kBq 131 I i.v. and separate groups were euthanised at seven time points from 1 h to 7 days after administration. 131 I concentration was determined in various collected organs and tissues, and mean absorbed dose per injected activity, D/A inj , was calculated. Results showed higher 131 I concentration and D/A inj in most organs in females than males except for kidneys, where males received fourfold higher D/A inj after 7 days (120 versus 31 mGy/MBq). The D/A inj in most organs in females was about up to approximately twofold higher than in males, while thyroid D/A inj was also higher in females, at 180,000 versus 140,000 mGy/MBq. In conclusion, sex-related differences in 131 I biodistribution between males and females were found in all investigated tissues at one or more time points, but the magnitude and timing of these differences varied between tissues. These findings support consideration of biological sex as a variable in preclinical biodistribution and dosimetry studies of radionuclides.
Authors
- Mikael Elvborn (ORCID: https://orcid.org/0000-0002-5470-1377)
- Eva B. Forssell-Aronsson (ORCID: https://orcid.org/0000-0002-7558-4368)
- Emman Shubbar
- Britta Langen (ORCID: https://orcid.org/0000-0002-3713-6169)
- Charlotte Ytterbrink
- Johan Spetz
Institutions
- Sahlgrenska University Hospital (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1038/s41598-026-77442-4
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancerfonden
- Vetenskapsrådet
- Sahlgrenska Universitetssjukhuset
- Strålsäkerhetsmyndigheten